Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., last night accepted the recommendation of her agency’s independent Advisory Committee on Immunization Practices to administer Pfizer’s pediatric COVID-19 vaccine to children between the ages of five and 11. Coupled with the Food and Drug Administration’s Oct. 29 emergency use authorization to Pfizer for its pediatric Covid-19 vaccine, this recommendation paves the way for the product’s administration to this age group immediately.

Related News Articles

Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The National Institutes of Health Sept. 16 announced it has launched a consortium to help reduce preventable stillbirths across the U.S. The NIH said…
Headline
A blog by Julia Resnick, AHA senior director of health outcomes and care transformation, describes a new project with the Commonwealth Fund that will explore…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Blog
Every pregnant woman deserves access to high-quality maternal care — from conception through postpartum. Yet in parts of the country, some of that care is…